Actively Recruiting
68Ga-grazytracer PET/CT for Early Assessment of Response to Neoadjuvant Immunotherapy in Resectable NSCLC
Led by Ruijin Hospital · Updated on 2025-01-01
40
Participants Needed
1
Research Sites
156 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this study is to explore the effectiveness of 68Ga-grazytracer PET/CT in early evaluation of neoadjuvant immunotherapy response in resectable NSCLC.
CONDITIONS
Official Title
68Ga-grazytracer PET/CT for Early Assessment of Response to Neoadjuvant Immunotherapy in Resectable NSCLC
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Clinical stage IB to IIIA (AJCC/UICC 8th Edition) before treatment
- Resectable lung cancer confirmed by an experienced surgeon
- Histologically confirmed primary non-small cell lung cancer
- Men and women aged 18 to 75 years
- Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1
- Expected survival of at least 6 months
- Signed informed consent form
You will not qualify if you...
- Diagnosis other than non-small cell lung cancer
- Lung cancer that cannot be surgically removed or has distant metastasis
- Previous cancers except certain skin and in situ cancers unless complete remission was achieved at least 2 years ago with no further therapy needed
- Active or past autoimmune diseases or history requiring systemic steroids or immunosuppressants
- Immunodeficiency conditions such as HIV or active hepatitis B or C
- Uncontrolled diabetes or fasting blood glucose higher than 11.0 mmol/L
- Women who are pregnant or breastfeeding
- History of severe heart disease, severe bone marrow suppression, or severe liver or kidney failure
- History of organ or stem cell transplantation
- Any medical or psychological condition preventing study completion or understanding of study information
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Shanghai, Shanghai Municipality, China, 200025
Actively Recruiting
Research Team
H
Hecheng Li, MD, PHD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here